State Of Tennessee, Treasury Department Gilead Sciences, Inc. Transaction History

State Of Tennessee, Treasury Department

$27.8 Billion
Q3 2024

A detailed history of State Of Tennessee, Treasury Department transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, State Of Tennessee, Treasury Department holds 551,650 shares of GILD stock, worth $50 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

551,650

Previous 453,607 21.61%

Holding current value

$50 Million

Previous $31.1 Million 48.58%

% of portfolio

0.17%

Previous 0.12%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $6.53 Million - $8.23 Million	98,043 Added 21.61%	551,650 $46.2 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $755,210 - $871,571	-11,959 Reduced 2.57%	453,607 $31.1 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $42,303 - $51,588	-591 Reduced 0.13%	465,566 $34.1 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $18.1 Million - $20.5 Million	-246,917 Reduced 34.63%	466,157 $37.8 Million
Q2 2023 Aug 15, 2023	BUY	$76.01 - $86.7 $3.1 Million - $3.54 Million	40,837 Added 6.07%	713,074 $55 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $361,733 - $412,126	4,679 Added 0.7%	672,237 $55.8 Million
Q4 2022 Feb 15, 2023	BUY	$62.32 - $89.47 $20.9 Million - $30 Million	335,091 Added 100.79%	667,558 $57.3 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $7.52 Million - $8.46 Million	130,200 Added 64.37%	332,467 $20.6 Million
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $2.72 Million - $3.41 Million	-47,045 Reduced 18.87%	202,267 $12 Million
Q4 2021 Feb 15, 2022	SELL	$64.88 - $73.64 $2.65 Million - $3.01 Million	-40,872 Reduced 14.08%	249,312 $18.1 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $4.52 Million - $4.88 Million	66,789 Added 29.9%	290,184 $20.3 Million
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $2,856 - $3,120	-45 Reduced 0.02%	223,395 $15.4 Million
Q1 2021 May 10, 2021	SELL	$60.0 - $68.46 $91,800 - $104,743	-1,530 Reduced 0.68%	223,440 $14.4 Million
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $27.4 Million - $31.2 Million	-483,418 Reduced 68.24%	224,970 $13.1 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $25.4 Million - $32 Million	409,270 Added 136.83%	708,388 $44.8 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $12.3 Million - $14.3 Million	-170,717 Reduced 36.34%	299,118 $23 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $24.8 Million - $31.8 Million	-396,278 Reduced 45.75%	469,835 $35.1 Million
Q4 2019 Feb 06, 2020	SELL	$61.62 - $67.78 $265,089 - $291,589	-4,302 Reduced 0.49%	866,113 $56.3 Million
Q3 2019 Oct 30, 2019	BUY	$62.51 - $69.0 $5.45 Million - $6.02 Million	87,192 Added 11.13%	870,415 $55.2 Million
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $12.6 Million - $14.2 Million	-204,188 Reduced 20.68%	783,223 $52.9 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $34 Million - $38.1 Million	544,218 Added 122.79%	987,411 $64.2 Million
Q4 2018 Feb 11, 2019	BUY	$60.54 - $79.0 $3.54 Million - $4.62 Million	58,484 Added 15.2%	443,193 $27.7 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $14.1 Million - $15.6 Million	-197,914 Reduced 33.97%	384,709 $29.7 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $11.5 Million - $13.4 Million	-177,083 Reduced 23.31%	582,623 $41.3 Million
Q1 2018 May 11, 2018	BUY	$72.84 - $88.8 $30.7 Million - $37.5 Million	421,779 Added 124.81%	759,706 $57.3 Million
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $46 Million - $54 Million	-646,682 Reduced 65.68%	337,927 $24.2 Million
Q3 2017 Nov 01, 2017	BUY	$72.11 - $85.47 $71 Million - $84.2 Million	984,609	984,609 $79.8 Million

Others Institutions Holding GILD

# of Institutions

1,930

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.

Account

State Of Tennessee, Treasury Department Gilead Sciences, Inc. Transaction History